Safety and efficacy of biological agents in the treatment of Systemic Lupus Erythematosus (SLE)
Abstract Background To determine the safety and efficacy of biological agents used in the treatment of systemic lupus erythematosus (SLE) in adults. Methods Systematic review and meta-analysis following PRISMA guidelines. Data sources MEDLINE (through Pubmed), EMBASE, Cochrane library, Clinicaltrial...
Main Authors: | Justin Chan, Giles D. Walters, Prianka Puri, Simon H. Jiang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-10-01
|
Series: | BMC Rheumatology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s41927-023-00358-3 |
Similar Items
-
Monoclonal Antibodies for Systemic Lupus Erythematosus (SLE)
by: Gabriella Moroni, et al.
Published: (2010-01-01) -
Lupus Enteritis: An Uncommon Manifestation of Systemic Lupus Erythematosus as an Initial Presentation
by: Vishal Bodh, et al.
Published: (2017-07-01) -
Interferon alpha (IFN-α) in systemic lupus erythematosus (SLE)
by: Sara Moqbil, et al.
Published: (2022-11-01) -
A Case of Systemic Lupus Erythematosus with Cutaneous Leukocytoclastic Vasculitis Mimicking Bullous SLE
by: Fumi Miyagawa, et al.
Published: (2021-09-01) -
Immunophenotyping identifies distinct cellular signatures for systemic lupus erythematosus and lupus nephritis
by: Yi Tong V. Aw, et al.
Published: (2023-03-01)